As of 2025-07-12, the Relative Valuation of Adaptive Biotechnologies Corp (ADPT) is (18.77) USD. This relative valuation is based on P/E multiples. With the latest stock price at 11.82 USD, the upside of Adaptive Biotechnologies Corp based on Relative Valuation is -258.8%.
The range of the Relative Valuation is (19.92) - (18.80) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.3x - 34.9x | 22.3x |
| Forward P/E multiples | 17.5x - 20.1x | 17.9x |
| Fair Price | (19.92) - (18.80) | (18.77) |
| Upside | -268.6% - -259.1% | -258.8% |
| Date | P/E |
| 2025-07-11 | -12.69 |
| 2025-07-10 | -12.94 |
| 2025-07-09 | -12.78 |
| 2025-07-08 | -12.57 |
| 2025-07-07 | -12.57 |
| 2025-07-03 | -12.64 |
| 2025-07-02 | -12.30 |
| 2025-07-01 | -11.99 |
| 2025-06-30 | -12.48 |
| 2025-06-27 | -12.63 |
| 2025-06-26 | -13.02 |
| 2025-06-25 | -12.83 |
| 2025-06-24 | -11.41 |
| 2025-06-23 | -11.31 |
| 2025-06-20 | -11.12 |
| 2025-06-18 | -11.21 |
| 2025-06-17 | -10.86 |
| 2025-06-16 | -11.02 |
| 2025-06-13 | -11.05 |
| 2025-06-12 | -11.15 |
| 2025-06-11 | -11.39 |
| 2025-06-10 | -11.20 |
| 2025-06-09 | -11.19 |
| 2025-06-06 | -10.81 |
| 2025-06-05 | -10.57 |
| 2025-06-04 | -10.69 |
| 2025-06-03 | -10.65 |
| 2025-06-02 | -10.23 |
| 2025-05-30 | -10.20 |
| 2025-05-29 | -9.97 |
| 2025-05-28 | -9.80 |
| 2025-05-27 | -9.79 |
| 2025-05-23 | -9.56 |
| 2025-05-22 | -9.47 |
| 2025-05-21 | -9.74 |
| 2025-05-20 | -10.03 |
| 2025-05-19 | -9.85 |
| 2025-05-16 | -9.69 |
| 2025-05-15 | -9.54 |
| 2025-05-14 | -9.68 |
| 2025-05-13 | -9.95 |
| 2025-05-12 | -10.19 |
| 2025-05-09 | -9.67 |
| 2025-05-08 | -9.93 |
| 2025-05-07 | -9.44 |
| 2025-05-06 | -9.44 |
| 2025-05-05 | -10.74 |
| 2025-05-02 | -10.54 |
| 2025-05-01 | -7.88 |
| 2025-04-30 | -7.88 |